| Field | Specification |
|---|---|
| UniProt # | |
| Applications | |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Scientific Background
This ELISA kit applies to the in vitro quantitative determination of Rat BNP concentrations in serum, plasma and other biological fluids.
Assay Principle
This ELISA kit uses the Competitive-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with Rat BNP. During the reaction, Rat BNP in the sample or standard competes with a fixed amount of Rat BNP on the solid phase supporter for sites on the Biotinylated Detection Ab specific to Rat BNP. Excess conjugate and unbound sample or standard are washed away, and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns from blue to yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of Rat BNP in tested samples can be calculated by comparing the OD of the samples to the standard curve.
Performance Specifications
| Sensitivity | 18.75 pg/mL |
|---|---|
| Detection Range | 31.25-2000 pg/mL |
| Total Assay Time | 2 h 30 min |
| Compatible Sample Types | Serum, plasma and other biological fluids |
| Species Reactivity | Rat |
| Detection Method | Competitive |
| Precision (CV) | Both intra-CV and inter-CV are < 10%. |
| Recovery Rate | 80%-120% |
| Storage | 2-8℃,12 months |
✓ Research-Grade Validation
Specificity
This kit recognizes Rat BNP in samples.No significant cross-reactivity or interference between Rat BNP and analogues was observed
Safety & Regulatory
Handle reagents in accordance with institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for complete hazard and handling information. Contains components that may require special disposal procedures per local regulations.
This kit is validated for use with Serum, plasma and other biological fluids. For unlisted matrices (e.g., tissue lysate, urine), perform a spike-and-recovery experiment to confirm assay performance before generating reportable data. Sample dilution in the kit's provided diluent is recommended to minimize matrix interference.
The minimum detectable concentration (sensitivity) of this kit is 18.75 pg/mL. Values below this threshold should be reported as below the limit of detection (<LOD) and should not be extrapolated from the standard curve.
The total assay time from sample addition to absorbance reading is approximately 2 h 30 min, including all incubation, wash, and substrate steps. Hands-on time is typically 1–2 hours; most steps involve passive plate incubation. Plan the assay as a single uninterrupted session for best results.
Standard components of this Competitive ELISA Kit typically include: pre-coated microplate (96-well strip format), lyophilized or liquid recombinant BNP standard, detection antibody, streptavidin-HRP conjugate, TMB substrate, stop solution, wash buffer concentrate, and sample/standard diluent. Refer to the kit insert or datasheet for the exact component list and storage requirements.
This kit uses colorimetric (TMB/HRP) detection and requires a standard microplate absorbance reader capable of measuring at 450 nm. A reference wavelength of 570 nm or 630 nm is recommended to reduce background. No specialized fluorescence or luminescence reader is needed. Ensure the instrument is calibrated and the plate is clean and free of condensation before reading.
Tissue samples may contain endogenous or exogenous proteases during processing, leading to degradation of extracted proteins. Therefore, it's necessary to add protease inhibitors during processing to ensure the integrity of target proteins. If customers can keep samples cold and handle them quickly during processing, omitting the protease inhibitor may not have a significant effect. After preparation, samples should be tested promptly or immediately aliquoted and frozen at -20°C or -80°C.
What is the range of enzyme activity of your IL-2 freeze-dried powder
What is the principle of adding stop solution to stop color reaction in ELISA experiment?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis (2024) Signal Transduction and Targeted Therapy. 10.1038/s41392-024-01816-1
Dipyridamole Acts as Clinical Ferroptosis Inhibitor to Prevent from Tissue Injury (2025) Advanced Science. 10.1002/advs.202500566
c-FLIP Protects Cardiac Microcirculation in Sepsis-Induced Myocardial Dysfunction Via FUNDC1-Mediated Regulation of Mitochondrial Autophagy (2025) JACC-Basic to Translational Science. 10.1016/j.jacbts.2025.02.016
The isoproterenol-induced myocardial fibrosis: A biochemical and histological investigation (2024) BIOMEDICINE & PHARMACOTHERAPY. 10.1016/j.biopha.2024.116534
Astragaloside IV ameliorates sepsis-induced myocardial dysfunction by regulating NOX4/JNK/BAX pathway (2022) LIFE SCIENCES. 10.1016/j.lfs.2022.121123
Shuxuening injection improves myocardial injury after myocardial infarction by regulating macrophage polarization via the TLR4/NF-κB and PI3K/Akt signaling pathways (2025) PHYTOMEDICINE. 10.1016/j.phymed.2025.156418
Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation (2023) EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 10.1016/j.ejmech.2023.115542
Sulfoxaflor provokes progressive myocardial injury by disrupting HIF-1α/VEGFA signaling, redox balance, and inflammation: A comprehensive biochemical, echocardiographic, and histopathological approach (2026) Journal of Environmental Sciences. 10.1016/j.jes.2026.01.037
LCZ696 Protects against Diabetic Cardiomyopathy-Induced Myocardial Inflammation, ER Stress, and Apoptosis through Inhibiting AGEs/NF-κB and PERK/CHOP Signaling Pathways (2022) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 10.3390/ijms23031288
Natriuretic Peptides—New Targets for Neurocontrol of Blood Pressure via Baroreflex Afferent Pathway (2022) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 10.3390/ijms232113619
Targeted temperature management alleviates post-resuscitation myocardial dysfunction by inhibiting ferroptosis (2025) Cell Death Discovery. 10.1038/s41420-025-02356-5
The redox-active defensive Selenoprotein T as a novel stress sensor protein playing a key role in the pathophysiology of heart failure (2024) Journal of Translational Medicine. 10.1186/s12967-024-05192-w
The mechanism of Renshen-Fuzi herb pair for treating heart failure—Integrating a cardiovascular pharmacological assessment with serum metabolomics (2022) Frontiers in Pharmacology. 10.3389/fphar.2022.995796
Rutin Modulates MAPK Pathway Differently from Quercetin in Angiotensin II-Induced H9c2 Cardiomyocyte Hypertrophy (2021) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 10.3390/ijms22105063
An experimental study of early cardiovascular disease and risk factors in a collagen-induced arthritis rat model (2026) Frontiers in Immunology. 10.3389/fimmu.2026.1801144
Identification of potential biomarkers of inflammation-related genes for ischemic cardiomyopathy (2022) Frontiers in Cardiovascular Medicine. 10.3389/fcvm.2022.972274
Parkia speciosa Hassk. Empty Pod Extract Alleviates Angiotensin II-Induced Cardiomyocyte Hypertrophy in H9c2 Cells by Modulating the Ang II/ROS/NO Axis and MAPK Pathway (2021) Frontiers in Pharmacology. 10.3389/fphar.2021.741623
Centella asiatica (L.) Urb. Prevents Hypertension and Protects the Heart in Chronic Nitric Oxide Deficiency Rat Model (2021) Frontiers in Pharmacology. 10.3389/fphar.2021.742562
Renal Denervation Effects on Myocardial Fibrosis and Ventricular Arrhythmias in Rats with Ischemic Cardiomyopathy (2018) CELLULAR PHYSIOLOGY AND BIOCHEMISTRY. 10.1159/000489653
Mechanism exploration of Salvia miltiorrhiza Bunge against trastuzumab induced cardiotoxicity via multi-omics (2025) JOURNAL OF ETHNOPHARMACOLOGY. 10.1016/j.jep.2025.121031
Exploring the Multi-Faceted Effects of Berberine in Ameliorating Diastolic Dysfunction in Rats with Heart Failure with Preserved Ejection Fraction (2025) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 10.3390/ijms26104847
The enhanced Wnt/β-Catenin pathway upregulation by Sacubitril/Valsartan via neprilysin inhibition compared to valsartan in the rotenone induced Parkinson’s disease rat model (2025) NEUROPHARMACOLOGY. 10.1016/j.neuropharm.2025.110734
Cardioprotective Effect of Hydroalcohol Extract of Andaliman (Zanthoxylum acanthopodium DC.) Fruits on Doxorubicin-Induced Rats (2024) Pharmaceuticals. 10.3390/ph17030359
Perindopril Improves Cardiac Function by Enhancing the Expression of SIRT3 and PGC-1α in a Rat Model of Isoproterenol-Induced Cardiomyopathy (2020) Frontiers in Pharmacology. 10.3389/fphar.2020.00094
Pretreatment with Indole-3-Propionic Acid Attenuates Lipopolysaccharide-Induced Cardiac Dysfunction and Inflammation Through the AhR/NF-κB/NLRP3 Pathway (2024) Journal of Inflammation Research. 10.2147/JIR.S466777
